| __timestamp | PTC Therapeutics, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 520990000000 |
| Thursday, January 1, 2015 | 121816000 | 535405000000 |
| Friday, January 1, 2016 | 117633000 | 558755000000 |
| Sunday, January 1, 2017 | 4577000 | 495921000000 |
| Monday, January 1, 2018 | 12670000 | 659690000000 |
| Tuesday, January 1, 2019 | 12135000 | 1089764000000 |
| Wednesday, January 1, 2020 | 18942000 | 994308000000 |
| Friday, January 1, 2021 | 32328000 | 1106846000000 |
| Saturday, January 1, 2022 | 44678000 | 1244072000000 |
| Sunday, January 1, 2023 | 65486000 | 1431505000000 |
| Monday, January 1, 2024 | 1431505000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Takeda Pharmaceutical Company Limited, a global leader, and PTC Therapeutics, Inc., a niche player, offer a fascinating contrast in cost of revenue trends from 2014 to 2023. Takeda's cost of revenue has shown a steady increase, peaking at approximately 1.43 trillion in 2023, reflecting its expansive global operations and diverse product portfolio. In contrast, PTC Therapeutics, with a focus on rare diseases, experienced more volatility. Their costs surged by over 700% from 2017 to 2023, highlighting the challenges and investments required in niche markets. Notably, 2017 marked a low point for PTC, with costs at just 4.6 million, while Takeda's costs were over 100,000 times higher. This disparity underscores the scale and scope differences between these two pharmaceutical giants.
Cost of Revenue Trends: Pfizer Inc. vs PTC Therapeutics, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited
Cost of Revenue: Key Insights for Zoetis Inc. and PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Takeda Pharmaceutical Company Limited and Cytokinetics, Incorporated
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: United Therapeutics Corporation vs PTC Therapeutics, Inc.
Cost of Revenue: Key Insights for Halozyme Therapeutics, Inc. and PTC Therapeutics, Inc.
Cost of Revenue Comparison: Alkermes plc vs PTC Therapeutics, Inc.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Perrigo Company plc's Expenses
PTC Therapeutics, Inc. vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Dyne Therapeutics, Inc.